Navigation Links
AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
Date:9/7/2007

ORLANDO, Fla., Sept. 7 /PRNewswire/ -- Daniel B. Yarosh, PhD, President and CEO AGI Dermatics, will deliver the keynote presentation at the 11th Annual Sunscreen Symposium today in Lake Buena Vista, FL. The multi-day gathering (September 6th-9th) of cosmetic chemists is sponsored by the Florida chapter of the Society of Cosmetic Chemists. Dr. Yarosh will present "Beyond Sunscreens: DNA Repair and Photoaging" to the more than 250 cosmetic chemists from around the U.S. and throughout the world who are scheduled to attend.

"Photoaging in skin is an extremely complex process and the genomic revolution has given us tools to understand UV-induced damage at the cellular level," said Dr. Yarosh. "Events such as the Sunscreen Symposium provide a forum in which we can share knowledge and ideas with colleagues, and further the sunscreen advancements around the world."

Dr. Yarosh, widely recognized as a pioneer in the science of DNA repair, is the author of more than 100 scientific papers and two dozen patents. He is an active participant in international photobiology societies and the New York biotechnology community.

AGI Dermatics founded by Dr. Yarosh in 1985, has emerged as a world leader in DNA repair technology for skin and is best known for developing Dimericine(R) (T4N5), a drug in testing for treating patients with skin cancers and pre-cancers. The U.S. Food & Drug Administration recently granted Fast Track designation for Dimericine for treatment of solar and ultraviolet photosensitivity in patients with Xeroderma Pigmentosum (XP), a rare genetic disorder that blocks the body's natural ability to repair DNA damage caused by ultraviolet light.

AGI Dermatics is also the developer of Remergent, a doctor-dispensed skincare line based on the science of DNA repair.

AGI Dermatics is the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics
'/>"/>

SOURCE AGI Dermatics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Siemens health services president calls IT benefits unassailable
2. Wisconsin IT association names Gee president, CEO
3. Merge Healthcare promotes Bowers to president
4. Quintessence Biosciences names new president
5. VanderSanden appointed president of AT&T Wisconsin
6. Merge president steps down in wake of shareholder suits
7. Milwaukees PointOne appoints new president and CEO
8. Cars.com president slated for Milwaukee event
9. Sonic Foundry names new senior vice president
10. MyWeather names new president, marketing officer
11. At Berbee, president replaces founder as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... June 30, 2015. Biorem,s complete second quarter financial statements and MD&A ... HIGHLIGHTS: in ,000,s except earnings per shareThree-months ended , Six -months endedJune ... 2015 , 2014 Revenue , 4,709 ... Gross profit , 1,656 , 56 , ...
(Date:8/27/2015)... , Aug. 27, 2015 In response ... FedEx, UPS and The US Postal Service to ... classified as ,select agents, by the CDC, Marken ... handling these sensitive shipments. Marken uses ... regulations, trained and certified personnel to ensure the ...
(Date:8/26/2015)... MO (PRWEB) , ... August 26, 2015 , ... ... it is increasing its investment in the development and manufacture of highly valued ... The company’s scientific team's extensive expertise with protein chemistry has led to ...
(Date:8/26/2015)... 26, 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, ... today announced that the Company has been informed that ... wholly owned by Mr. Yuen Kam, chairman of the ... outstanding shares (the "Shares") of  Excellent China Healthcare Investment ...
Breaking Biology Technology:BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3Marken Ensures Safe Transportation Of Select Agents And Toxins 2Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3
... ChemDiv, Inc., a leading,chemistry-driven global contract research ... into a discovery collaboration with Achaogen, Inc.,South ... medicinal and synthetic,chemistry, ChemDiv will support Achaogen ... terms of the collaboration were,not disclosed., ...
... at year end; no equity financings expected in 2008, ... to continue in,2008; latest data for all programs to ... - Expansion of research and development investment in pharmacological, ... in 2008, CRANBURY, N.J., Jan. 29 Amicus ...
... Jan. 29 Surface Logix today announced ... trial of SLx-4090 in,dyslipidemia (high cholesterol and ... placebo-controlled Phase 2a study in 24,patients with ... in postprandial triglycerides and LDL-cholesterol,and was well ...
Cached Biology Technology:ChemDiv and Achaogen Enter Into a Discovery Collaboration 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 2Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 3Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 4Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 5Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 6Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 7Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 8Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 9Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 10Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 11Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 12Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 13Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements 14Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial 2Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial 3Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial 4
(Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
(Date:8/5/2015)... VIEW, Calif. , Aug. 5, 2015 ... exhibits continuous growth in applications, penetration into newer sectors, ... after year. The global biosensors space has seen the ... exited the market so far. (Photo - ... Frost & Sullivan, Analysis of the Global Biosensors ...
(Date:8/4/2015)... ) today reported financial and operating results for the second quarter ... quarter contract revenue of $ 85.2 million, a ... of 26 % , Second quarter adjusted ... royalties in the current quarter , Operating cash ... to present another strong financial quarter, with all our divisions achieving ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... to findings by UT Southwestern Medical Center researchers, individuals ... clots, or thrombosis, might someday receive therapy to prevent ... in a future issue of The Journal of ... underlying antiphospholipid syndrome (APS). "Patients with APS ...
... have recorded stunning images of the UK,s winter landscape ... have been observing the icy blast in the UK ... scientists have used two instruments, MERIS and AATSR, which ... observations on November 29th and December 1st. ...
... alteration of a single gene could cause some male ... improve diagnosis and clinical management of patients with disorders ... testis or ovary does not develop properly in the ... An international team including researchers from the ...
Cached Biology News:UT Southwestern researchers uncover culprits in life-threatening clotting disorder 2Snow from space: University of Leicester releases satellite images of snow-bound UK 2